EcoDrugPlus

Steroid 17-Alpha-Hydroxylase/17,20 Lyase

Ensembl ID : ENSSDUG00000015264
Gene Symbol: LOC111239202
3 Cross references
210 Possible Orthologues:

Steroid 5 Alpha-Reductase 2

Ensembl ID : ENSSDUG00000002399
Gene Symbol: SRD5A2
3 Cross references
191 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSSDUG00000000324
Gene Symbol: SOAT1
3 Cross references
210 Possible Orthologues:

Stress Response Protein Nst1-Like

Ensembl ID : ENSSDUG00000018018
Gene Symbol: LOC111230347
2 Cross references
196 Possible Orthologues:

Substance-P Receptor-Like

Ensembl ID : ENSSDUG00000023591
Gene Symbol: LOC111239669
3 Cross references
193 Possible Orthologues:

Synuclein Alpha

Ensembl ID : ENSSDUG00000015777
Gene Symbol: SNCA
4 Cross references
189 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSSDUG00000005198
Gene Symbol: TACR1
3 Cross references
195 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSSDUG00000022010
Gene Symbol: TACR2
3 Cross references
199 Possible Orthologues:

Tachykinin Receptor 3

Ensembl ID : ENSSDUG00000001040
Gene Symbol: TACR3
3 Cross references
208 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSSDUG00000001907
Gene Symbol: TERT
3 Cross references
189 Possible Orthologues:

Thromboxane A Synthase 1

Ensembl ID : ENSSDUG00000000314
Gene Symbol: TBXAS1
3 Cross references
219 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSSDUG00000007486
Gene Symbol: TBXA2R
3 Cross references
192 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).